Anaptysbio, inc (ANAB)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16
ASSETS
Current assets:
Cash and cash equivalents

165,317

171,017

182,898

146,552

105,853

113,596

293,408

57,057

69,474

81,189

26,669

30,752

96,754

51,232

Receivable from collaborative partners

5,000

0

-

5,000

-

-

5,000

-

-

-

0

0

0

1,225

Australian tax incentive receivable

-

-

0

0

175

174

173

152

1,610

1,601

1,486

5,637

4,965

4,118

Short-term investments

197,166

203,210

238,104

275,664

309,812

313,486

200,406

210,852

178,691

167,218

89,053

75,607

6,742

0

Prepaid expenses and other current assets

3,572

3,506

3,595

3,772

6,102

6,960

4,035

3,758

2,170

2,688

3,119

3,852

1,694

1,633

Total current assets

371,055

377,733

424,597

430,988

421,942

434,216

503,022

271,819

251,945

252,696

120,327

115,848

110,155

58,208

Property, Plant and Equipment, Net

1,610

1,618

1,695

1,481

1,584

1,445

1,344

1,086

659

665

513

543

569

471

Long-term investments

50,215

54,305

23,418

45,707

68,551

73,128

18,616

32,730

61,884

75,897

999

13,912

20,327

0

Other long-term assets

1,293

1,481

1,735

1,913

2,089

148

79

322

289

46

-

-

-

-

Long-term vendor deposits

-

-

-

-

-

-

-

-

-

-

46

46

-

0

Restricted cash

60

60

60

60

60

60

60

60

60

60

60

60

60

60

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

0

0

0

3,441

Total assets

424,233

435,197

451,505

480,149

494,226

508,997

523,121

306,017

314,837

329,364

121,945

130,409

131,111

62,180

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

8,571

16,237

10,522

10,921

9,072

5,443

6,180

4,426

2,416

2,323

2,557

3,724

2,546

2,278

Accrued Liabilities, Current

13,781

11,052

15,286

14,102

8,400

8,761

7,145

4,837

4,405

4,875

3,604

3,230

4,330

3,429

Notes payable, current portion

0

1,375

3,077

4,781

6,488

7,574

7,500

7,500

7,500

6,875

5,000

3,125

1,250

0

Other current liabilities

898

871

845

819

794

58

48

27

22

17

13

0

0

1

Total current liabilities

23,250

29,535

29,730

30,623

24,754

21,836

20,873

16,790

14,343

14,090

11,174

10,079

8,126

5,708

Other long-term liabilities

419

654

883

1,105

1,317

796

-

-

-

-

-

-

-

-

Notes payable, net of current portion

-

-

-

-

-

-

2,409

4,120

5,834

7,553

9,269

10,987

12,709

13,809

Deferred rent

-

-

-

-

-

-

162

128

133

140

147

168

161

154

Preferred stock warrant liabilities

-

-

-

-

-

-

-

-

-

-

0

0

0

3,241

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

0

0

0

0

Stockholders’ equity:
Preferred stock, $0.001 par value, 10,000 shares authorized and no shares, issued or outstanding at March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value, 500,000 shares authorized, 27,277 shares and 27,255 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

27

27

27

27

27

27

27

24

24

24

20

20

20

3

Additional paid in capital

651,680

648,669

644,148

640,550

636,692

633,251

629,887

399,370

395,424

393,017

179,551

178,297

176,507

16,672

Accumulated other comprehensive income

1,145

338

480

574

204

-223

-541

-677

-801

-426

-43

-59

-13

0

Accumulated deficit

-252,288

-244,026

-223,763

-192,730

-168,768

-146,690

-129,696

-113,738

-100,120

-85,034

-78,173

-69,083

-66,399

-54,923

Total stockholders’ equity

400,564

405,008

420,892

448,421

468,155

486,365

499,677

284,979

294,527

307,581

101,355

109,175

110,115

-38,248

Total liabilities and stockholders’ equity

424,233

435,197

451,505

480,149

494,226

508,997

523,121

306,017

314,837

329,364

121,945

130,409

131,111

62,180